tiprankstipranks
Santhera Pharmaceuticals Holding (GB:0QN1)
LSE:0QN1

Compare Santhera Pharmaceuticals Holding (0QN1) vs. Competitors

3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Santhera Pharmaceuticals Holding
CHF17.17
CHF251.58M
-0.98
32.32%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF127.99M
-2.50
1.54%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF668.92M
16.63
36.21%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.69
CHF887.80M
-8.17
231.05%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF16.66
CHF340.38M
-9.69
155.42%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF21.20
CHF115.35M
3.93
13.16%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0QN1
Santhera Pharmaceuticals Holding
18.05
3.75
26.21%
CH:MOLN
Molecular Partners AG
3.30
0.02
0.61%
CH:BSLN
Basilea Pharmaceutica
56.80
15.10
36.21%
CH:IDIA
Idorsia Ltd
3.67
2.54
226.33%
CH:NWRN
Newron Pharmaceuticals SpA
16.96
10.54
164.17%
CH:XLS
Xlife Sciences Ltd.
21.50
2.05
10.54%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts